Cambridge Healthtech Institute’s Inaugural

Intelligent Antibody Discovery

Functional Screening, Predicting Biotherapeutic Properties, Covid-19 R&D Case Studies

January 17-18, 2022


Peptalk’s inaugural Intelligent Antibody Discovery conference offers delegates a unique opportunity to explore the contributions of new science and technologies to discovery and early-stage biopharmaceutical development. The meeting examines the evolution of display methods and the role of tailored library design and how repertoire screening platforms are now being applied to new targets and capabilities. These new directions will be illustrated with case examples of rapid COVID-19 R&D projects and their use with challenging target classes. 


Opportunities for Participation:



For priority consideration, respond by June 25, 2021.


All proposals for podium presentations are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, the integrity of our agendas allows us to deliver a high-quality audience year after year. We have been able to accomplish this by selecting presentations from pharmaceutical and large biotech companies, academia, and government and national labs. A select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. Indicate your interest in giving a podium, poster or sponsor presentation by clicking the appropriate link above.



For more details on the conference, please contact:

Kent Simmons

Senior Conference Director

Cambridge Healthtech Institute

Phone: 207-329-2964



For sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: +1 781-972-5452



Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: +1 781-972-1340